TERM ID="NYU_TERM_1" STRING="DPP-4" FREQUENCY=1 START=877 END=882 LEMMA="DIPEPTIDYL PEPTIDASE 4" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_2" STRING="GLP-1" FREQUENCY=1 START=820 END=825 LEMMA="GLUCAGON LIKE PEPTIDE 1" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_3" STRING="Newer antidiabetes agents" FREQUENCY=1 START=756 END=781 LEMMA="NEWER ANTIDIABETES AGENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_4" STRING="Redefining treatment success" FREQUENCY=1 START=0 END=28 LEMMA="REDEFINING TREATMENT SUCCESS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_5" STRING="blood glucose" FREQUENCY=1 START=700 END=713 LEMMA="BLOOD GLUCOSE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_6" STRING="cardiovascular disease" FREQUENCY=1 START=196 END=218 LEMMA="CARDIOVASCULAR DISEASE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_7" STRING="cardiovascular risk" FREQUENCY=1 START=1011 END=1030 LEMMA="CARDIOVASCULAR RISK" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_8" STRING="comorbidities" FREQUENCY=1 START=637 END=650 LEMMA="COMORBIDITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_9" STRING="comprehensive approach" FREQUENCY=1 START=512 END=534 LEMMA="COMPREHENSIVE APPROACH" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_10" STRING="decreased insulin secretion" FREQUENCY=1 START=360 END=387 LEMMA="DECREASED INSULIN SECRETION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_11" STRING="diabetes mellitus" FREQUENCY=2 START=39 END=56 LEMMA="DIABETES MELLITUS" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_12" STRING="diabetes mellitus" FREQUENCY=2 START=150 END=167 LEMMA="DIABETES MELLITUS" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_13" STRING="dipeptidyl peptidase-4" FREQUENCY=2 START=853 END=875 LEMMA="DIPEPTIDYL PEPTIDASE-4" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_14" STRING="dipeptidyl peptidase-4" FREQUENCY=2 START=853 END=875 LEMMA="DIPEPTIDYL PEPTIDASE-4" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_15" STRING="disease progression" FREQUENCY=1 START=489 END=508 LEMMA="DISEASE PROGRESSION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_16" STRING="evolving concepts" FREQUENCY=1 START=426 END=443 LEMMA="EVOLVING CONCEPT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_17" STRING="fundamental defects" FREQUENCY=2 START=594 END=613 LEMMA="FUNDAMENTAL DEFECT" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_18" STRING="fundamental defects" FREQUENCY=2 START=904 END=923 LEMMA="FUNDAMENTAL DEFECT" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_19" STRING="glucagon-like peptide-1" FREQUENCY=2 START=795 END=818 LEMMA="GLUCAGON-LIKE PEPTIDE-1" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_20" STRING="glucagon-like peptide-1" FREQUENCY=2 START=795 END=818 LEMMA="GLUCAGON-LIKE PEPTIDE-1" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_21" STRING="incretin hormones" FREQUENCY=1 START=468 END=485 LEMMA="INCRETIN HORMONE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_22" STRING="lipids" FREQUENCY=1 START=748 END=754 LEMMA="LIPID" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_23" STRING="nonoptimal control" FREQUENCY=1 START=678 END=696 LEMMA="NONOPTIMAL CONTROL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_24" STRING="overweight/obesity" FREQUENCY=1 START=176 END=194 LEMMA="OVERWEIGHT/OBESITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_25" STRING="pathophysiology" FREQUENCY=1 START=307 END=322 LEMMA="PATHOPHYSIOLOGY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_26" STRING="potential effects" FREQUENCY=1 START=973 END=990 LEMMA="POTENTIAL EFFECT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_27" STRING="public health burdens" FREQUENCY=1 START=249 END=270 LEMMA="PUBLIC HEALTH BURDEN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_28" STRING="receptor agonists" FREQUENCY=1 START=827 END=844 LEMMA="RECEPTOR AGONIST" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_29" STRING="redefinition" FREQUENCY=1 START=1034 END=1046 LEMMA="REDEFINITION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_30" STRING="redefinition of treatment success" FREQUENCY=1 START=1034 END=1067 LEMMA="TREATMENT SUCCESS REDEFINITION" LEMMA_FREQUENCY=1 HEAD_TERM="redefinition" HEAD_LEMMA="REDEFINITION"
TERM ID="NYU_TERM_31" STRING="sequelae" FREQUENCY=2 START=230 END=238 LEMMA="SEQUELAE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_32" STRING="sequelae" FREQUENCY=2 START=666 END=674 LEMMA="SEQUELAE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_33" STRING="sequelae of nonoptimal control" FREQUENCY=1 START=666 END=696 LEMMA="NONOPTIMAL CONTROL SEQUELAE" LEMMA_FREQUENCY=1 HEAD_TERM="sequelae" HEAD_LEMMA="SEQUELAE"
TERM ID="NYU_TERM_34" STRING="sequelae of nonoptimal control of blood glucose" FREQUENCY=1 START=666 END=713 LEMMA="BLOOD GLUCOSE NONOPTIMAL CONTROL SEQUELAE" LEMMA_FREQUENCY=1 HEAD_TERM="sequelae of nonoptimal control" HEAD_LEMMA="NONOPTIMAL CONTROL SEQUELAE"
TERM ID="NYU_TERM_35" STRING="treatment success" FREQUENCY=1 START=1050 END=1067 LEMMA="TREATMENT SUCCESS" LEMMA_FREQUENCY=1
